TriLink Biotechnologies

About TriLink Biotechnologies

TriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucl


  • US
  • 2022
    On CPHI since
Contact info
  • Wateridge Cir Ste 200,, 10770, San Diego, California, United States

Products from TriLink Biotechnologies (3)

  • CleanCap® mRNA Capping Reagent

    Product CleanCap® mRNA Capping Reagent

    CleanCap technology is a “one-pot” solution that reduces the number of steps, equipment required, and time to produce a 5’ Cap 1 mRNA structure with 95% efficiency, providing a modern alternative to enzymatic capping. Available in GMP grade, CleanCap reagents offer an immediate solution for swiftly scaling...
  • Custom mRNA Synthesis

    Product Custom mRNA Synthesis

    Since 2012, TriLink has been the industry leader in custom messenger RNA (mRNA) synthesis for research and clinical applications. We manufacture non-coding RNAs and provide tailored synthesis at milligram to multigram scales, with lengths ranging from a few hundred nucleotides to greater than 10 kilobases....
  • GMP Manufacturing Services

    Product GMP Manufacturing Services

    TriLink operates a state-of-the-art Current Good Manufacturing Practice (cGMP) production facility. As the leading manufacturer of mRNA, nucleotides, nucleoside triphosphates, and oligos, our unparalleled experience, technical expertise, and scalability make us an ideal partner for clinical or preclinical ...